Zunveyl – BioWorld
... Purchase, N.Y.-based company (NASDAQ:CGTX) falling 44%, or $1.04, to close July 29 at $1.33. Read More. Popular Stories. Today's news in brief.
Day: July 29, 2024
Despite endpoint miss, Cognition sees path forward in Alzheimer’s | BioWorld
... Alzheimer's disease and sending shares of the Purchase, N.Y.-based company (NASDAQ:CGTX) falling 44%, or $1.04, to close July 29 at $1.33.
15 Cities Where Inflation Is Causing Property Taxes To Rise the Most | GOBankingRates
2023 Median Home Price: $1,225,000. Purchase, NY. Zip code: 10577; County: Westchester; 2023 Median Property Tax: $29,675; 2023 Median Home Price ...
Allan Deering Obituary (1934 – 2024) – Medway, MA – GreenwichTime – Legacy.com
... Purchase, NY as Vice President. During his career, he was in leadership positions in many industry groups. He was especially proud that he was a ...
Cognition Therapeutics’ stock tumbles as trial of oral treatment for mild to moderate … – Morningstar
The Purchase, N.Y.-based company (CGTX) said the trial, called Shine, found patients treated for six months with its experimental pill CT1812 met ...
Cognition Therapeutics announces positive results from trial of oral treatment for mild … – Morningstar
The Purchase, N.Y.-based company (CGTX) said the trial, called Shine, found patients treated with its experimental pill CT1812 for six months ...
Cognition Therapeutics’ Proof-of-Concept Phase 2 SHINE Trial Demonstrates Consistent …
PURCHASE, N.Y., July 29, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage ...
Cognition Therapeutics announces positive results from trial of oral treatment for mild-to …
The Purchase, N.Y.-based company said the trial, called Shine, found patients treated with CT1812 for six months showed a consistent trend in ...